Sageworth Trust’s Biogen BIIB Stock Holding History

Sageworth Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4	Closed	-$1K	–	200
2020 Q2	$1K	Buy	+4	New	+$1.2K	﹤0.01%	175
2019 Q2	–	Sell	-78	Closed	-$18K	–	183
2019 Q1	$18K	Buy	78 +76	+3,800%	+$23.9K	﹤0.01%	146
2018 Q4	$1K	Buy	+2	New	+$638	﹤0.01%	129
2018 Q2	–	Sell	-43	Closed	-$12K	–	145
2018 Q1	$12K	Buy	+43	New	+$13.3K	﹤0.01%	77
2017 Q3	–	Sell	-244	Closed	-$66K	–	71
2017 Q2	$66K	Buy	+244	New	+$64.5K	0.01%	52

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sageworth Trust's BIIB Position: Q3 2020 in Review

Sageworth Trust sold out of Biogen (BIIB) in Q3 2020, closing a stake of 4 shares — an estimated $1K sold.

Sageworth Trust first reported a position in BIIB in Q2 2017 and held it in 5 quarters. The position peaked at $66K in Q2 2017. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Sageworth Trust reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Sageworth Trust sold 4 Biogen shares in Q3 2020, an estimated $1K.
Sageworth Trust first reported a position in Biogen in Q2 2017 and held it in 5 quarters.
Sageworth Trust's Biogen position peaked at $66K in Q2 2017.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Sageworth Trust's 13F filing for Q3 2020, filed 4 Nov 2020.